Tony Mills
Tony Mills M.D. | |
---|---|
Born |
Columbia, South Carolina | October 12, 1961
Alma mater |
Duke University Duke University School of Medicine |
Occupation | Physician |
Spouse(s) | Sandro Antunes (July 2014) |
Tony Mills, M.D., is an American physician who specializes in treatment of HIV and AIDS.[1] He is one of the leading clinician in the fields of Men's Health and HIV disease. Dr. Mills has served as the primary care provider for over 2,000 patients, including approximately half living with HIV. Dr. Mills received both his undergraduate and medical degrees from Duke University. He completed an internship in Internal Medicine, a residency in Anesthesiology and a fellowship in Cardiovascular Anesthesiology, all at the University of California, San Francisco. Dr. Mills is a member of many professional societies including; the Infectious Disease Society of America, International AIDS Society, IAS-USA, and the American Academy of HIV Medicine. He is currently the Executive Director of SoCal Men's Medical Group, the Clinical Research Director of Mills Clinical Research, and the President of the Men's Health Foundation.
In May 1998, he won the title of International Mister Leather, publicly coming out as HIV-positive one day later.[2]
Education
- 1981 - B.A., Duke University; Durham, North Carolina
- 1984 - Fellowship, Cardiovascular Research Institute; University of California, San Francisco
- 1986 - M.D., Duke University School of Medicine; Durham, North Carolina
- 1987 - Internship in Internal Medicine; University of California, San Francisco
- 1989 - Residency in Anesthesiology; University of California, San Francisco
- 1990 - Fellowship in Cardiovascular Anesthesiology; University of California, San Francisco
Mills graduated from Duke University School of Medicine and was awarded both the Stanley Sarnoff Fellowship Award in Cardiovascular Research and the Eugene Stead Research Award. He began his clinical practice in 1991 at Columbia Presbyterian Medical Center in New York City, concentrating on heart transplantation and cardiovascular research.
In 1994, Mills was named Chief of Pediatric Cardiac Anesthesiology at the University of Miami,[3] where he was actively involved in both the recovery community and in the gay community as an advocate for people living with HIV.
In 1999, he moved to Los Angeles and opened a general medical practice specializing in HIV care. He was certified as an HIV specialist by the American Academy of HIV Medicine in 2000 and currently serves on both the California Board and the National Board of the AAHIVM. In 2002, Mills joined the Clinical Medicine Faculty at UCLA where he works actively with residents and fellows and is a frequent lecturer.[1]
He is the current editor of HIV Treatment News and is a frequent contributor to other HIV-related publications.
Occupational History
- 1991 - 1992: Assistant Professor in Anesthesiology; Division of Cardiothoracic Anesthesia, College of Physicians and Surgeons of Columbia University; New York, New York.
- 1993 - 1994: Assistant Professor in Anesthesiology; Division of Trauma, Neurosurgery, and Cardiac Anesthesia, Mount Sinai Medical Center; New York, New York.
- 1994 - 1995: Assistant Professor in Anesthesiology; Director, Pediatric Cardiac Anesthesiology; University of Miami Medical Center; Miami, Florida.
- 2002–Present: Assistant Professor of Clinical Medicine, University of California, Los Angeles School of Medicine; Los Angeles, California.
- 2000–Present: Medical Director, Anthony M. Mills, M.D., Inc. - A Medical Corporation
- 2004–Present: Director of Clinical Research, SoCal Men's Medical Group
- 2004–Present: Clinical Laboratory Research Director, Mills Clinical Research
- 2013–Present: President of the Men's Health Foundation.
The Tony Mills Medical Practice, based in Los Angeles, California, has been devoted to delivering holistic healthcare focused on nutrition, exercise and well-being over 15 years. His approach goes beyond the immediate treatment of his patients through the nurturing of health behaviors and, ultimately, by giving his patients the structure and opportunity to build and maintain a healthy lifestyle. The overall goal is to work with each of his patients to achieve a higher level of wellness. Through extensive research, the Tony Mills Medical Practice is able to offer the most up-to-date therapies for his patients' medical needs.
Over the past decade, Dr. Mills has been the Principal Investigator in over 100 Clinical Trials. Many of these trials have been presented at national and international conferences as well as been published in peer-reviewed medical journals.
The Men's Health Foundation
The Men’s Health Foundation is proud to be a part of the national CDC funded provider network to implement high-impact prevention strategies to help reduce the number of new HIV infections and STDs among men and increase the number of men engaged in medical care. These strategies include testing and linkage to care, prevention for negatives (condoms, PrEP, risk reduction counseling) and prevention for positives (Treatment as Prevention).
A leader in the provision of PrEP, the Men’s Health Foundation is currently conducting two PrEP investigator research studies – one for those who have fallen out of PrEP care and another for transgender women. Staff is also engaged in a national PrEP clinical training program that is targeting 15 cities nationally to increase clinical knowledge on PrEP as well as greater access to this proven prevention strategy. Community trainings in multiple U.S. cities and large Men’s Health Summits in key parts of Los Angeles County are underway.
The Men’s Health Foundation is in planning to open a community-based clinic in an underserved part of Los Angeles County to provide HIGH-QUALITY men’s healthcare and prevention services and a cadre of wraparound programs to support retention in care: mental health counseling, patient care coordination, PrEP navigation and benefits counseling.
The Men’s Health Foundation will create and promote service delivery models that facilitate and expand linkage to care, social service and other internal or external service providers to increase retention in care, improve medical outcomes and provide comprehensive support services for men, especially young GBTQ men of color, regardless of HIV status.
The Men’s Health Foundation will work in strategic partnerships with service providers to expand the range of care, treatment and services available to men, especially young men at risk for STDS and HIV/AIDS.
Anthony Mills, MD is a recognized leader in men’s healthcare and research. As Medical Director of the Southern California Men’s Medical Group, Dr. Mills oversees a staff of thirty-five employees, including seven clinicians and a clinical research division who serve 7,000 male patients. As Executive Director of the Men’s Health Foundation, Dr. Mills is supervising high-impact prevention care and treatment for young men at risk for HIV and is in planning on a community-based clinic that offers integrated men’s healthcare and HIV specialty care with wraparound services of mental health and patient navigation services in an underserved area of Los Angeles County. Dr. Mills has been the Principal Investigator in over 100 clinical trials, is an accredited HIV physician and serves as an Assistant Professor of Clinical Medicine at UCLA.
Board Certification
- 1991 - Diplomat, American Board of Anesthesiology
Professional Activities
- 2004–Present: Olympia Medical Center; Member of the Executive & Physician Well Being Committee's & Chairman of the Institutional Review Board
- 2006–Present: AIDS Research Alliance; Institutional Review Board
- 2011 - Certified Clinical Research Professional
- 2014 - Provider Representative for the Los Angeles County Commission on HIV
Honors and Awards
- 1978 - National Merit Scholar
- 1981 - Magnum Cum Laude, Duke University
- 1983 - Eugene Stead Fellowship for Student Research
- 1984 - Stanley J. Sarnoff Fellowship for Cardiovascular Research
- 1999 - Certification of Honor, Board of Supervisors of San Francisco, CA; For His Outstanding Service to a Significant Portion of the People of the City and County of San Francisco
- 2003 - California State Legislature's Award for Community Service
- 2010 - American Society for Coloscopy and Cervical Pathology (ASCCP); For His Participation in the Educational Activity Entitled High Resolution Anoscopy at the InterContental Mark Hopkins Hotel
- 2010 - Ronald S. Gelb Community Service Award; For His Dedication, Service, Care, and Advocacy to the LGBT Senior, & HIV/AIDS Communities
- 2013 - Spirit of Hope Award; For His Dedication to Improving the Lives of People Living with HIV/AIDs
Professional Societies
- Infection Disease Society of America
- HIV Medical Association
- American Academy of HIV Medicine
- American Society of Microbiology
- International AIDs Society - USA
- International AIDs Society
Past Research
- 1984 - 1985: Stanley J. Sarnoff Fellowship for Cardiovascular Research (Developmental Myocardinal Function)
- 1989 - 1990: Cardiac Anesthesia Research Fellowship (Uptake of Anesthetic Agents During Cardiopulmonary Bypass; Cerebral Protection during Cardiopulmonary Bypass; Trans-esophageal Echocardiography during Cardiac Surgery)
- 2000: The Effect of Oxymetholone on Body Composition in HIV Positive Patients with Lipodystrophy
- 2000: Safety and Efficacy of ABT378/r in Patients with HIV (EAP)
- 2000: Safety and Efficacy of Tenofovir in Patients with HIV (EAP)
- 2001 - 2002: Observational Weight Loss Registry (Oxandrolone)
- 2002 - 2003: BMS-232632 Phase IIIB Atazanavir (EAP)
- 2002 - 2003: Roche MV16812-Fuzeon (EAP)
- 2003: ESS30005 - Glaxo Smith Kline Zaigen Intensification Protocol
- 2003: AUG-TG-214 Auxilium Testim START Study
- 2004: AUX-TG-218 - Testim Therapy for HIV Positive non-responders to Androgel
- 2004: ESS 100327-ACTION Study
- 2004: UMD-95-009-Nitazoxanide for Treatment of Crpytosporidium in AIDS Patients
- 2004: ML 18021-ENHANCE Study
- 2004: TMC 125-C223-Phase II- TMC 125 in Treatment experienced patients
- 2005: Roche-SQVRTV 3 Day PK
- 2005: BI 1182.70-Tipranavir (EAP)
- 2005 - 2007: ELECT 100290-Phase IIIb/IV - Elective Switch of PI to fos-amprenavir
- 2005 - 2006: EPIC-CCR10136- Phase IIb Trial of GW 873140 in Treatment Naïve Patients
- 2005 - 2007: GSK CCR5 Phase III Trials GW873140 in Treatment-Experienced Patients
- 2006 - 2007: ACH443-015 Phase II Elvucitabine vs. Lamivudine
- 2006 - 2007: ABC107442 SHAPE Retrospective Case Control Study
- 2006 - 2007: AI226-073 Phase IV Atripla vs. Unmodified HAART
- 2007 - 2008: TMC125 EAP
- 2007 - 2008: MK0518 EAP
- 2005 - 2008: Pfizer A4001027-UK-427,857 in Treatment Experienced Patients
- 2005 - 2008: TMC125-C206 and C217-DUET-Phase-III-TMC125 + TMC 114 Treatment Experienced Patients
- 2005 - 2008: TMC125-C229-Phase IIb Rollover Trail of Treatment Experienced Patients
- 2005 - 2008: IMPACT-Phase IV0I50L; Substitution in Patients Failing Atazanavir
- 2005 - 2008: EPZ104057 HEAT: Epzicom vs. Truvada with Kaletra in Naïve Patients
- 2007: ML20837 Phase IV Fuzeon Once Daily With MK0518
- 2007: INCB9471-201 Phase 2B Pharmacokinetics and Virological Effect of Once Daily Oral Dosing
- 2007 - 2009: MK0518-032 Phase IV-MK0518 vs. Kaletra
- 2007 - 2009: BIPI 1100.1512 NEWART Phase IV - Viramune XR vs. Atazanavir
- 2007 - 2010: PO4889; Victor-E4 Phase III - Vicriviroc in Combination Treatment with OBR
- 2008 - 2009: GS0US-164-0216: Phase III, ABC/3TC to TDF/FTC Switch in Subjects on Ritonavir Boosted PI
- 2008 - 2009: P05241; Effect of Vicriviroc on HIV RNA Levels in CSF
- 2008 - 2010: BIPI 1100.1486; VERVXE Phase III - NVP XR vs. NVP BID - Naïve
- 2009 - 2010: BIPI 1100.1526; TRANXITION Phase IIIb NVP IR vs. NVP XR - Experienced
- 2011: GS-US-120-0104; GS-7340 (NRTI) Monotherapy PK Study - Naïve
- 2008 - 2011: TMC278-C209; ECHO-Phase III TMC278 vs. EFV + TDF/FTC
- 2008 - 2011: MK0518-071; Phase IV - MK0518 BID vs. MK0518 QD
- 2009 - 2011: A400-1078; Maraviroc vs. Truvada with Atazanavir/r - Naïve
Current Research Projects
Pfizer
- 2009 - A527-1022 UK453,061; Etravirine with Darunavir/r - Experienced
- 2011 - A527-1037; Long Term Open Label Extension Study of Lersivirine
- 2011 - A400-1095 Maraviroc Plus DAR/r vs. Tenofovir Plus DAR/r
Gilead Sciences
- 2008 - GS-US-183-0144 and 0145; Phase III - Elvitegravir/r vs. Raltegravir - Experienced
- 2010 - GS-US-236-0102; Quad vs. Atripla - Naïve
- 2010 - GS-US-236-0103; Quad vs. TDF/FTC/ATV/r - Naïve
- 2010 - GS-US-236-0114; GS-9.50 vs. Ritonavir + ATV/TDF/FTC - Naïve
- 2011 - GS-US-264-0111; ATRIPLA Switch from FTC/RPV/TDF (STR)
- 2011 - GS-US-264-0110; ATRIPLA v. FTC/RPV/TDF (STR) Naïve
- 2011 - GS-US-264-0106; PI/r NRTI Switch to FTC/RPV/TDF (STR)
- 2011 - GS-US-236-0115; PI/r Plus Truvada Switch to FTC/RPV/TDF (STR)
- 2011 - GS-US-236-0121; NNRTI Plus Truvada Switch to FTC/RPV/TDF
- 2011 - GS-US-292-0102; ELV/COBI/EMT/GS-7340 (STR) vs. ELV/COBI/EMT/TDF
GlaxoSmithKline
- 2010 - ING113086; GSK1349572 vs. RAL with a Fixed Dose Dual NRTI - Naïve
- 2011 - ING117062; GSK1349572 vs. RAL plus Two Agents ne Being Fully Active - Experienced
- 2011 - ING114467; GSK1349572 plus EPZ v Atripla - Naïve
- 2011 - ING114915; GSK1349572 ve. DRV/r each administered with a Fixed Dual NRTI
- 2011 - ING116070; GSK1349572 (DTG) plus ABC/3TC Safety, Efficacy and Central Nervous System
KOWA
- 2011 - NK104.4-05US; Pitavastatin vs. Pravastatin in HIV Positive Subjects
SUMAGEN
- 2012 - SAV CT01; SAV001-H Safety and Tolerability
International Mister Leather
On May 5, 1998, having earned the regional title of Mister Mid-Atlantic Leather, Mills entered and won the International Mister Leather contest, competing against 61 contestants from 7 countries.
Since winning the contest, Mills has been featured in the documentaries Beyond Vanilla and Mr. Leather.[4][5] He has also been a model for the COLT Studio Group.[2]
References
External links
- Antiretroviral Highlights from CROI: Video interview with Dr. Mills – aidsmeds.com
- International Mister Leather website
- SoCal Men's Medical Group
- Mills Clinical Research
- Men's Health Foundation
- Men's Health Foundation Facebook Page